Can a DIY fertility test help you plan when to have a baby?
By Zoë Corbyn,
The Guardian
| 01. 21. 2018
My sisters, aged 27 and 30, are seated at their computers poring over the slick websites of companies promising to reveal secrets to them about their fertility. “Get insight into how your fertility is tracking relative to your age,” promises one. “Get the tools you need to have more control over your fertility,” says a second. “Gauge how long you have left to conceive,” says a third. The tests, which look at the levels of one or more female hormones in the blood, style themselves as easy to order and are less than what one would pay in a fertility clinic. “The information seems relatively cheap and readily available, so why not find out?” says my older sister. “I just assumed I wouldn’t have any fertility issues,” says the younger. “I realise after looking at these websites I probably shouldn’t assume this.”
These companies are the latest outgrowth of the growing global market in fertility services. Fuelled by women delaying childbirth longer, it includes IVF and egg freezing and is expected to generate $21bn (£15.5bn) in revenue globally by 2020...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026